Juvenescence Ltd buys 801,924 shares of AgeX Therapeutics, Inc. [AGE]
Transaction increases the holding of Juvenescence Ltd in the company to 801,924
By USInMinutes
Published - Feb 17, 2023, 07:57 AM ET
Last Updated - Feb 19, 2023, 08:57 AM EST
Juvenescence Ltd has bought 801,924 shares of Agex Therapeutics, Inc. [AGE] at $0.00 a share.Agex Therapeutics, Inc. [AGE] disclosed in an SEC Form 4 submission Thursday, February 16, 2023 that the deal increased Juvenescence Ltd's holding in the company to 801,924.Agex Therapeutics, Inc. [AGE] is a Pharmaceutical Preparations company based in Delaware.
Although all care is taken to ensure the accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications.